Stay updated on ENZAMET: First Line Androgen Deprivation Therapy Clinical Trial
Sign up to get notified when there's something new on the ENZAMET: First Line Androgen Deprivation Therapy Clinical Trial page.

Latest updates to the ENZAMET: First Line Androgen Deprivation Therapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now lists a new 'Revision: v3.3.2' entry and drops the previous 'Revision: v3.3.1' entry. This is a minor internal update to the page's versioning and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed; these are administrative updates to the page's version history and do not alter the study data or main content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedNotice about government funding and operating status at the top of the page has been removed. The notice was informational and did not affect the study data or page content.SummaryDifference0.6%

- Check43 days agoChange DetectedThe latest version (2025-02-03) updated the Study Status and Sponsor/Collaborators sections. It added a Compare option to review changes.SummaryDifference0.1%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference12%

- Check79 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.3%

Stay in the know with updates to ENZAMET: First Line Androgen Deprivation Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENZAMET: First Line Androgen Deprivation Therapy Clinical Trial page.